FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Maher Albitar

Research Profile

Disorders

Concepts & Ideas

Chemicals & Drugs

Anatomy

Bone Marrow

Procedures

Physiology

Mutation

Co-author Network

Publications

TOP 3
Alireza Minagar; Xiuqiang Wang; Ke Zhang; Xi Zhang; J Steven Alexander; Eduardo Gonzalez-Toledo; Wanlong Ma; Maher Albitar
Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
Claudia Ulrike Walter; Hazzaa Al Zahrani; Mahmoud Aljurf; Fahad Alsharif; NA Chaudhri; Wahiba Chebbo; Ghada El Gohary; Said Mohamed; Fahad Al Mohareb; Walid Rasheed; Abu Jafar Saleh; Maher Albitar
The t(9;11) confers good prognosis in AML patients treated with stem cell transplantation as compared to non-t(9;11) and other adverse-risk abnormalities.
Sofiya Reicher; Bruce E Stabile; Vladimira Sulcova; Rose Venegas; Ying Zhou; Fatih Z Boyar; David S Chung; Viktor E Eysselein; Samuel W French; Gang Li; Visal Nga; Sally Agersborg; Maher Albitar; Arturo Anguiano
Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Maher Albitar (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2012: Alireza Minagar; Xiuqiang Wang; Ke Zhang; Xi Zhang; J Steven Alexander; Eduardo Gonzalez-Toledo; Wanlong Ma; Maher Albitar
Plasma ubiquitin-proteasome system profile in patients with multiple sclerosis: correlation with clinical features, neuroimaging, and treatment with interferon-beta-1b.
Neurological research 2012;34(6):611-8.
2012: Claudia Ulrike Walter; Hazzaa Al Zahrani; Mahmoud Aljurf; Fahad Alsharif; NA Chaudhri; Wahiba Chebbo; Ghada El Gohary; Said Mohamed; Fahad Al Mohareb; Walid Rasheed; Abu Jafar Saleh; Maher Albitar
The t(9;11) confers good prognosis in AML patients treated with stem cell transplantation as compared to non-t(9;11) and other adverse-risk abnormalities.
Hematology/oncology and stem cell therapy 2012;5(3):169-70.
2011: Sofiya Reicher; Bruce E Stabile; Vladimira Sulcova; Rose Venegas; Ying Zhou; Fatih Z Boyar; David S Chung; Viktor E Eysselein; Samuel W French; Gang Li; Visal Nga; Sally Agersborg; Maher Albitar; Arturo Anguiano
Fluorescence in situ hybridization and K-ras analyses improve diagnostic yield of endoscopic ultrasound-guided fine-needle aspiration of solid pancreatic masses.
Pancreas 2011;40(7):1057-62.
2011: Aziza Nassar; Allen Olson; Jim Thompson; Burton L Vanderbilt; Weidong Zhou; Sally S Agersborg; Maher Albitar; Edward A Barker; Cynthia Cohen; Eugene R Heyman; Holger Lange; Kathleen A Lynch; Momin T Siddiqui
Trainable immunohistochemical HER2/neu image analysis: a multisite performance study using 260 breast tissue specimens.
Archives of pathology & laboratory medicine 2011;135(7):896-902.
2011: Paul G Richardson; Asher A Chanan-Khan; Sagar Lonial; Amrita Y Krishnan; Michael P Carroll; Melissa Alsina; Maher Albitar; David Berman; Marianne Messina; Kenneth C Anderson
Tanespimycin and bortezomib combination treatment in patients with relapsed or relapsed and refractory multiple myeloma: results of a phase 1/2 study.
British journal of haematology 2011;153(6):729-40.
2011: W Ma; Francis Giles; X Zhang; X Wang; Z Zhang; T-S Lee; C-H Yeh; Maher Albitar
Three novel alternative splicing mutations in BCR-ABL1 detected in CML patients with resistance to kinase inhibitors.
International journal of laboratory hematology 2011;33(3):326-31.
2011: Aziza Nassar; Cynthia Cohen; Maher Albitar; Sally S Agersborg; Weidong Zhou; Kathleen A Lynch; Eugene R Heyman; Holger Lange; Momin T Siddiqui
Reading immunohistochemical slides on a computer monitor--a multisite performance study using 180 HER2-stained breast carcinomas.
Applied immunohistochemistry & molecular morphology : AIMM / official publication of the Society for Applied Immunohistochemistry 2011;19(3):212-7.
2011: Kevin Z Qu; Ke Zhang; Wanlong Ma; Hairong Li; Xiuqiang Wang; Xi Zhang; Francis Giles; Michelle Lai; Nezam H Afdhal; Maher Albitar
Ubiquitin-proteasome profiling for enhanced detection of hepatocellular carcinoma in patients with chronic liver disease.
Journal of gastroenterology and hepatology 2011;26(4):751-8.
2011: Kevin Z Qu; Ke Zhang; HaiRong Li; Nezam H Afdhal; Maher Albitar
Circulating microRNAs as biomarkers for hepatocellular carcinoma.
Journal of clinical gastroenterology 2011;45(4):355-60.
2011: Wanlong Ma; Hagop Kantarjian; Xi Zhang; Xiuiang Wang; Zeev Estrov; Susan O'Brien; Maher Albitar
Ubiquitin-proteasome system profiling in acute leukemias and its clinical relevance.
Leukemia research 2011;35(4):526-33.
2011: Wanlong Ma; Xi Zhang; Xiuqiang Wang; Zhong Zhang; Chen-Hsiung Yeh; Jennifer Uyeji; Maher Albitar
MPL mutation profile in JAK2 mutation-negative patients with myeloproliferative disorders.
Diagnostic molecular pathology : the American journal of surgical pathology, part B 2011;20(1):34-9.
2011: Tai-Sung Lee; Wanlong Ma; Chen-Hsiung Yeh; Francis Giles; Hagop Kantarjian; Maher Albitar
Effects of clinically relevant MPL mutations in the transmembrane domain revealed at the atomic level through computational modeling.
PloS one 2011;6(8):e23396.
2011: Heather R Sanders; Hai-Rong Li; Jean-Marie Bruey; Jay A Scheerle; Aurelia M Meloni-Ehrig; JoAnn C Kelly; Constance Novick; Maher Albitar
Exon scanning by reverse transcriptase-polymerase chain reaction for detection of known and novel EML4-ALK fusion variants in non-small cell lung cancer.
Cancer genetics 2011;204(1):45-52.
2010: Heather R Sanders; Maher Albitar
Somatic mutations of signaling genes in non-small-cell lung cancer.
Cancer genetics and cytogenetics 2010;203(1):7-15.
2010: Jean-Marie Bruey; Andrew Lamb; Wanlong Ma; Zeev Estrov; Chenhsiung Yeh; Amber Donahue; Heather Sanders; Susan O'Brien; Michael Keating; Maher Albitar
Circulating Ki-67 index in plasma as a biomarker and prognostic indicator in chronic lymphocytic leukemia.
Leukemia research 2010;34(10):1320-4.
2010: Paul G Richardson; Ashraf Badros; Sundar Jagannath; Stefano Tarantolo; Jeffrey L Wolf; Maher Albitar; David Berman; Marianne Messina; Kenneth C Anderson
Tanespimycin with bortezomib: activity in relapsed/refractory patients with multiple myeloma.
British journal of haematology 2010;150(4):428-37.
2010: Paul G Richardson; Asher A Chanan-Khan; Melissa Alsina; Maher Albitar; David Berman; Marianne Messina; Constantine S Mitsiades; Kenneth C Anderson
Tanespimycin monotherapy in relapsed multiple myeloma: results of a phase 1 dose-escalation study.
British journal of haematology 2010;150(4):438-45.
2010: Richard L Chang; Chen-Hsiung Yeh; Maher Albitar
Quantification of intracellular proteins and monitoring therapy using flow cytometry.
Current drug targets 2010;11(8):994-9.
2010: Adam Abdool; Chen-Hsiung Yeh; Andrew Lamb; Susan O'Brien; JeanMarie Bruey; Francis Giles; Maher Albitar
Circulating CD33 and its clinical value in acute leukemia.
Experimental hematology 2010;38(6):462-71.
2010: Chen-Hsiung Yeh; Richard Tseng; Alison Hannah; Zeev Estrov; Elihu Estey; Andrew Lamb; Maher Albitar
Clinical correlation of circulating heat shock protein 70 in acute leukemia.
Leukemia research 2010;34(5):605-9.
2010: Gheath Alatrash; Maher Albitar; Susan O'Brien; Xuemei Wang; Taghi Manshouri; Stefan Faderl; Alessandra Ferrajoli; Jan Burger; Guillermo Garcia-Manero; Hagop M Kantarjian; Susan Lerner; Michael J Keating; Jan A Burger
Circulating CD52 and CD20 levels at end of treatment predict for progression and survival in patients with chronic lymphocytic leukaemia treated with fludarabine, cyclophosphamide and rituximab (FCR).
British journal of haematology 2010;148(3):386-93.
2010: Jean-Marie Bruey; Andrew Lamb; Zeev Estrov; Zhong Zhang; Wanlong Ma; Ferras Albitar; Adam Abdool; Deborah Thomas; Chenhsiung Yeh; Susan O'Brien; Maher Albitar
Circulating Ki-67 protein in plasma as a biomarker and prognostic indicator of acute lymphoblastic leukemia.
Leukemia research 2010;34(2):173-6.
2010: Wanlong Ma; Andrew Lamb; Ke Zhang; Xi Zhang; Xiuqiang Wang; Clifford Chen; Amber C Donahue; Zhong Zhang; Chen-Hsiung Yeh; Susan O'Brien; Guillermo Garcia-Manero; Neil Caporaso; Ola Landgren; Maher Albitar
Significant association between polymorphism of the erythropoietin gene promoter and myelodysplastic syndrome.
BMC medical genetics 2010;11():163.
2010: Gerald E Marti; Youn K Shim; Maher Albitar; Dan Middleton; Fatima Abbasi; Ayana Anderson; Robert F Vogt
Long-term follow-up of monoclonal B-cell lymphocytosis detected in environmental health studies.
Cytometry. Part B, Clinical cytometry 2010;78 Suppl 1():S83-90.
2010: Wanlong Ma; Andrew Lamb; Xi Zhang; Xiuqiang Wang; Zhong Zhang; Chen-Hsiung Yeh; Susan O'Brien; Francis Giles; Jean-Marie Bruey; Maher Albitar
JAK2 exon 14 deletion in patients with chronic myeloproliferative neoplasms.
PloS one 2010;5(8):e12165.
2009: Huei-Ting Tsai; Neil E Caporaso; Robert A Kyle; Jerry A Katzmann; Angela Dispenzieri; Richard B Hayes; Gerald E Marti; Maher Albitar; Paolo Ghia; S Vincent Rajkumar; Ola Landgren
Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study.
Blood 2009;114(24):4928-32.
2009: Francis Giles; Norbert Vey; Daniel J DeAngelo; Karen Seiter; Wendy Stock; Robert Stuart; Darinka Boskovic; Arnaud Pigneux; Martin S Tallman; Joseph Brandwein; Jonathan Kell; Tadeusz Robak; Peter Staib; Xavier Thomas; Ann Cahill; Maher Albitar; Susan O'Brien
Phase 3 randomized, placebo-controlled, double-blind study of high-dose continuous infusion cytarabine alone or with laromustine (VNP40101M) in patients with acute myeloid leukemia in first relapse.
Blood 2009;114(19):4027-33.
2009: Jorge E Cortes; Hagop M Kantarjian; Stuart L Goldberg; Bayard L Powell; Francis Giles; Meir Wetzler; Luke Akard; John M Burke; Robert Kerr; Mansoor Saleh; August Salvado; Karen McDougall; Maher Albitar; Jerald P Radich
High-dose imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: high rates of rapid cytogenetic and molecular responses.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(28):4754-9.
2009: David P Steensma; Maria R Baer; James L Slack; Rena Buckstein; Lucy A Godley; Guillermo Garcia-Manero; Maher Albitar; Julie S Larsen; Sujata Arora; Michael T Cullen; Andrew Lamb
Multicenter study of decitabine administered daily for 5 days every 4 weeks to adults with myelodysplastic syndromes: the alternative dosing for outpatient treatment (ADOPT) trial.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2009;27(23):3842-8.
2009: Michael E Rytting; Andrew Lamb; Maher Albitar
Acute lymphoblastic leukemia with Burkitt-like morphologic features and high myeloperoxidase activity.
American journal of clinical pathology 2009;132(2):182-5; quiz 306.
2009: Maher Albitar; Steven Potts; Francis Giles; Susan O'Brien; Iman Jilani; Amber C Donahue; Elihu H Estey; Andrew Lamb
Proteomics-based prediction of clinical response in acute myeloid leukemia.
Experimental hematology 2009;37(7):784-90.
2009: Tai-Sung Lee; Steven Potts; Maher Albitar
Basis for resistance to imatinib in 16 BCR-ABL mutants as determined using molecular dynamics.
Recent patents on anti-cancer drug discovery 2009;4(2):164-73.
2009: Wanlong Ma; Andrew Lamb; Benjamin Bekele; Amber C Donahue; Xi Zhang; Zhong J Zhang; Susan O'Brien; Elihu Estey; Zeev Estrov; Jorge Cortes; Michael Keating; Francis Giles; Maher Albitar
Proteasome enzymatic activities in plasma as risk stratification of patients with acute myeloid leukemia and advanced-stage myelodysplastic syndrome.
Clinical cancer research : an official journal of the American Association for Cancer Research 2009;15(11):3820-6.
2009: Chen-Hsiung Yeh; Richard Tseng; Maher Albitar
Plasma-based detection of clonality in lymphoid malignancies.
European journal of haematology 2009;82(6):450-3.
2009: Stefan Faderl; Ashutosh Pal; William G Bornmann; Maher Albitar; David Maxwell; Quin Van; Zhenghong Peng; David Harris; Zhiming Liu; Inbal Hazan-Halevy; Hagop M Kantarjian; Zeev Estrov
Kit inhibitor APcK110 induces apoptosis and inhibits proliferation of acute myeloid leukemia cells.
Cancer research 2009;69(9):3910-7.
2009: Tai-Sung Lee; Wanlong Ma; Xi Zhang; Francis Giles; Andrew Lamb; Maher Albitar
Mechanisms of constitutive activation of Janus kinase 2-V617F revealed at the atomic level through molecular dynamics simulations.
Cancer 2009;115(8):1692-700.
2009: Maher Albitar; Chenhsiung Yeh; Wanlong Ma
K-ras mutations and cetuximab in colorectal cancer.
The New England journal of medicine 2009;360(8):834; author reply 835-6.
2009: Ola Landgren; Maher Albitar; Wanlong Ma; Fatima Abbasi; Richard Hayes; Paolo Ghia; Gerald E Marti; Neil E Caporaso
B-cell clones as early markers for chronic lymphocytic leukemia.
The New England journal of medicine 2009;360(7):659-67.
2009: Chen-Hsiung Yeh; Richard Tseng; Zhong Zhang; Jorge Cortes; Susan O'Brien; Francis Giles; Alison Hannah; Zeev Estrov; Michael Keating; Andrew Lamb; Maher Albitar
Circulating heat shock protein 70 and progression in patients with chronic myeloid leukemia.
Leukemia research 2009;33(2):212-7.
2009: Iman Jilani; C Wei; B N Bekele; Z J Zhang; M Keating; W Wierda; Alessandra Ferrajoli; Zeev Estrov; Andrew Lamb; S M O'Brien; Francis Giles; Maher Albitar
Soluble syndecan-1 (sCD138) as a prognostic factor independent of mutation status in patients with chronic lymphocytic leukemia.
International journal of laboratory hematology 2009;31(1):97-105.
2009: Tai-Sung Lee; Wanlong Ma; Xi Zhang; Andrew Lamb; Maher Albitar
Structural effects of clinically observed mutations in JAK2 exons 13-15: comparison with V617F and exon 12 mutations.
BMC structural biology 2009;9():58.
2009: Wanlong Ma; Andrew Lamb; Chen-Hsiung Yeh; Zhong J Zhang; Jorge Cortes; Maher Albitar
BCR-ABL truncation due to premature translation termination as a mechanism of resistance to kinase inhibitors.
Acta haematologica 2009;121(1):27-31.
2009: Wanlong Ma; Andrew Lamb; Xi Zhang; Iman Jilani; Mohammad Sheikholeslami; Amber C Donahue; Farhad Ravandi; Elihu Estey; Susan O'Brien; Michael Keating; Francis Giles; Maher Albitar
Detection of nucleophosmin gene mutations in plasma from patients with acute myeloid leukemia: clinical significance and implications.
Cancer biomarkers : section A of Disease markers 2009;5(1):51-8.
2009: Wanlong Ma; Andrew Lamb; Xi Zhang; Chen-Hsiung Yeh; Zhong J Zhang; Srdan Verstovsek; Maher Albitar
Mutation profile of JAK2 transcripts in patients with chronic myeloproliferative neoplasias.
The Journal of molecular diagnostics : JMD 2009;11(1):49-53.
2008: Chen-Hsiung Yeh; William A Whitmire; Maher Albitar
Liquid-based fluorescence in situ hybridization assay for detection of ERBB2 gene amplification in patients with breast cancer.
Clinical chemistry 2008;54(11):1831-9.
2008: Apostolia-Maria Tsimberidou; Elihu Estey; Sijin Wen; Sherry Pierce; Andrew Lamb; Maher Albitar; Razelle Kurzrock
The prognostic significance of cytokine levels in newly diagnosed acute myeloid leukemia and high-risk myelodysplastic syndromes.
Cancer 2008;113(7):1605-13.
2008: Dennis Smiler; Muna Soltan; Maher Albitar
Toward the identification of mesenchymal stem cells in bone marrow and peripheral blood for bone regeneration.
Implant dentistry 2008;17(3):236-47.
2008: Iman Jilani; Andrew Lamb; Homan Faraji; Mercedes Gorre; Jorge Cortes; Oliver G Ottmann; Kapil N Bhalla; Susan O'Brien; Francis Giles; Maher Albitar
An immunological method for the detection of BCR-ABL fusion protein and monitoring its activation.
Leukemia research 2008;32(6):936-43.
2008: David A Rizzieri; Eric Feldman; John F Dipersio; Nashat Gabrail; Wendy Stock; Roger Strair; Victor M Rivera; Maher Albitar; Camille L Bedrosian; Francis Giles
A phase 2 clinical trial of deforolimus (AP23573, MK-8669), a novel mammalian target of rapamycin inhibitor, in patients with relapsed or refractory hematologic malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2008;14(9):2756-62.
2008: Tai-Sung Lee; Steven Potts; Andrew Lamb; Jorge Cortes; Francis Giles; Maher Albitar
Molecular basis explanation for imatinib resistance of BCR-ABL due to T315I and P-loop mutations from molecular dynamics simulations.
Cancer 2008;112(8):1744-53.
2008: Wanlong Ma; Andrew Lamb; Xi Zhang; Weimin Sun; Arlene M Buller; Iman Jilani; Joyce G Schwartz; Francis Giles; Maher Albitar
Higher detection rate of JAK2 mutation using plasma.
Blood 2008;111(7):3906-7.
2008: Iman Jilani; Andrew Lamb; Mercedes Gorre; Jorge Cortes; Oliver G Ottmann; Kapil N Bhalla; Francis Giles; Maher Albitar
Phosphorylation levels of BCR-ABL, CrkL, AKT and STAT5 in imatinib-resistant chronic myeloid leukemia cells implicate alternative pathway usage as a survival strategy.
Leukemia research 2008;32(4):643-9.
2008: Wanlong Ma; Andrew Lamb; Susan O'Brien; Iman Jilani; Xi Zhang; Zeev Estrov; Alessandra Ferrajoli; Michael Keating; Francis Giles; Maher Albitar
Enzymatic activity of circulating proteasomes correlates with clinical behavior in patients with chronic lymphocytic leukemia.
Cancer 2008;112(6):1306-12.
2007: Joanne Bareng; Iman Jilani; Mercedes Gorre; Andrew Lamb; Francis Giles; Alison Hannah; Maher Albitar
A potential role for HSP90 inhibitors in the treatment of JAK2 mutant-positive diseases as demonstrated using quantitative flow cytometry.
Leukemia & lymphoma 2007;48(11):2189-95.
2007: Mohammad Sheikholeslami; Wanlong Ma; Jennifer Uyeji; Karl Tornyos; Lawrence Cone; Steven Mamus; Maher Albitar
Bi-clonal disease in patients with chronic lymphocytic leukaemia as detected by analysing IGHV mutation status.
British journal of haematology 2007;139(3):507-9.
2007: Francis Giles; Maher Albitar
Plasma-based testing as a new paradigm for clinical testing in hematologic diseases.
Expert review of molecular diagnostics 2007;7(5):615-23.
2007: Francis Giles; Alan F List; Michael Carroll; Jorge E Cortes; Joyce Valickas; Bee-Lian Chen; Eric Masson; Christian Jacques; Dirk Laurent; Maher Albitar; Eric J Feldman; Gail J Roboz
PTK787/ZK 222584, a small molecule tyrosine kinase receptor inhibitor of vascular endothelial growth factor (VEGF), has modest activity in myelofibrosis with myeloid metaplasia.
Leukemia research 2007;31(7):891-7.
2007: Farhad Ravandi; Iman Jilani; Elihu Estey; Andrew Lamb; A Dey; C Aguilar; C Jitkaroon; Francis Giles; Susan O'Brien; Michael Keating; Maher Albitar
Soluble phosphorylated fms-like tyrosine kinase III. FLT3 protein in patients with acute myeloid leukemia (AML).
Leukemia research 2007;31(6):791-7.
2007: Maher Albitar; M Johnson; Kim-Anh Do; A Day; Iman Jilani; S Pierce; E Estey; H Kantarjian; M Keating; S Verstovsek; S O'brien; Francis Giles
Levels of soluble HLA-I and beta2M in patients with acute myeloid leukemia and advanced myelodysplastic syndrome: association with clinical behavior and outcome of induction therapy.
Leukemia 2007;21(3):480-8.
2007: Wanlong Ma; Richard Tseng; Mercedes Gorre; Iman Jilani; Michael Keating; Andrew Lamb; Jorge Cortes; Susan O'Brien; Francis Giles; Maher Albitar
Plasma RNA as an alternative to cells for monitoring molecular response in patients with chronic myeloid leukemia.
Haematologica 2007;92(2):170-5.
2007: Francis Giles; Gautam Borthakur; Farhad Ravandi; Stefan Faderl; Srdan Verstovsek; Deborah Thomas; William G Wierda; Alessandra Ferrajoli; Steven M Kornblau; Sherry Pierce; Maher Albitar; Jorge Cortes; Andrew Lamb
The haematopoietic cell transplantation comorbidity index score is predictive of early death and survival in patients over 60 years of age receiving induction therapy for acute myeloid leukaemia.
British journal of haematology 2007;136(4):624-7.
2007: Maher Albitar; Julie M Vose; Marcella M Johnson; Kim-Anh Do; Amanda Day; Iman Jilani; Andrew Lamb; Michael Keating; Susan M O'Brien; Srdan Verstovsek; James O Armitage; Francis Giles
Clinical relevance of soluble HLA-I and beta2-microglobulin levels in non-Hodgkin's lymphoma and Hodgkin's disease.
Leukemia research 2007;31(2):139-45.
2007: Huai En Huang Chan; Iman Jilani; Richard Chang; Maher Albitar
Detection of chromosome translocations by bead-based flow cytometry.
Methods in molecular biology (Clifton, N.J.) 2007;378():167-74.
2007: Huai En Huang Chan; Iman Jilani; Richard Chang; Maher Albitar
Measuring humanized antibodies in plasma of patients treated with antibody-based therapy using bead-based flow cytometry: the story of alemtuzumab.
Methods in molecular biology (Clifton, N.J.) 2007;378():159-65.
2007: Huai En Huang Chan; Iman Jilani; Richard Chang; Maher Albitar
Cell-free bead-based detection of total and phosphorylated proteins in plasma and cell lysates: detection of FLT3.
Methods in molecular biology (Clifton, N.J.) 2007;378():153-7.
2007: Huai En Huang Chan; Iman Jilani; Richard Chang; Maher Albitar
Monitoring cell signaling pathways by quantitative flow cytometry.
Methods in molecular biology (Clifton, N.J.) 2007;378():83-90.
2007: Huai En Huang Chan; Iman Jilani; Richard Chang; Maher Albitar
Quantification of surface antigens and quantitative flow cytometry.
Methods in molecular biology (Clifton, N.J.) 2007;378():65-9.
2007: Mohammad Sheikholeslami; Iman Jilani; Maher Albitar
He use of the antibodies in the diagnosis of leukemia and lymphoma by flow cytometry.
Methods in molecular biology (Clifton, N.J.) 2007;378():53-63.
2007: Francis Giles; David A Rizzieri; Judith E Karp; Norbert Vey; Farhad Ravandi; Stefan Faderl; Khuda Dad Khan; Gregor Verhoef; Pierre W Wijermans; Anjali Advani; Gail J Roboz; Andrew Lamb; Syed Fazl Ali Bilgrami; Augustin Ferrant; S M G J Daenen; Verena Karsten; Ann Cahill; Maher Albitar; Ghulam Mufti; Susan O'Brien
Cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients age 60 years or older with previously untreated acute myeloid leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2007;25(1):25-31.
2006: Francis Giles; Srdan Verstovsek; Stefan Faderl; Norbert Vey; Judith E Karp; Gail J Roboz; Khuda Dad Khan; Maureen Cooper; Syed Fazl Ali Bilgrami; Augustin Ferrant; S M G J Daenen; Verena Karsten; Ann Cahill; Maher Albitar; Andrew Lamb; Susan O'Brien; Eric Feldman
A phase II study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, in patients with very high risk relapsed acute myeloid leukemia.
Leukemia research 2006;30(12):1591-5.
2006: W Ma; Andrew Lamb; Iman Jilani; Mercedes Gorre; Kapil N Bhalla; Oliver G Ottmann; Francis Giles; Maher Albitar
Heterogeneity in detecting Abl kinase mutations and better sensitivity using circulating plasma RNA.
Leukemia 2006;20(11):1989-91.
2006: Iman Jilani; M Keating; A Day; W William; Andrew Lamb; S O'brien; Francis Giles; Maher Albitar
Simplified sensitive method for the detection of B-cell clonality in lymphoid malignancies.
Clinical and laboratory haematology 2006;28(5):325-31.
2006: Karen W L Yee; Zhihong Zeng; Marina Konopleva; Srdan Verstovsek; Farhad Ravandi; Alessandra Ferrajoli; Deborah Thomas; William G Wierda; Efrosyni Apostolidou; Maher Albitar; Susan O'Brien; Michael Andreeff; Francis Giles
Phase I/II study of the mammalian target of rapamycin inhibitor everolimus (RAD001) in patients with relapsed or refractory hematologic malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(17):5165-73.
2006: Francis Giles; Thomas Fischer; Jorge Cortes; Guillermo Garcia-Manero; Joachim Beck; Farhad Ravandi; Eric Masson; Patricia Rae; Glen Laird; Sunil Sharma; Andrew Lamb; Margaret Dugan; Maher Albitar; Kapil N Bhalla
A phase I study of intravenous LBH589, a novel cinnamic hydroxamic acid analogue histone deacetylase inhibitor, in patients with refractory hematologic malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(15):4628-35.
2006: W Ma; Andrew Lamb; Srdan Verstovsek; Iman Jilani; Mercedes Gorre; Francis Giles; J Cortes; S O'Brien; M Keating; Maher Albitar
Hemizygous/homozygous and heterozygous JAK2 mutation detected in plasma of patients with myeloproliferative diseases: correlation with clinical behaviour.
British journal of haematology 2006;134(3):341-3.
2006: Charles Koller; B Nebiyou Bekele; Xian Zhou; Charles Park; Zeev Estrov; Susan O'Brien; Michael Keating; Iman Jilani; Francis Giles; Hagop M Kantarjian; Maher Albitar
Plasma thrombopoietin compared with immunoglobulin heavy-chain mutation status as a predictor of survival in chronic lymphocytic leukemia.
Blood 2006;108(3):1001-6.
2006: Francis Giles; Srdan Verstovsek; Guillermo Garcia-Manero; Deborah Thomas; Farhad Ravandi; William G Wierda; Alessandra Ferrajoli; Steven M Kornblau; Elias Jabbour; Jianqin Shan; Susan O'Brien; Maher Albitar; Andrew Lamb
Validation of the European Prognostic Index for younger adult patients with acute myeloid leukaemia in first relapse.
British journal of haematology 2006;134(1):58-60.
2006: Andrew Lamb; Francis Giles; Lydia Wunderle; Kapil N Bhalla; Susan O'Brien; Barbara Wassmann; Chiaki Tanaka; Paul Manley; Patricia Rae; William Mietlowski; Kathy Bochinski; Andreas Hochhaus; James D Griffin; Dieter Hoelzer; Maher Albitar; Margaret Dugan; Jorge Cortes; Leila Alland; Oliver G Ottmann
Nilotinib in imatinib-resistant CML and Philadelphia chromosome-positive ALL.
The New England journal of medicine 2006;354(24):2542-51.
2006: W Ma; Iman Jilani; Mercedes Gorre; M Keating; H Chan; R Tseng; Andrew Lamb; S O'Brien; Francis Giles; Maher Albitar
Plasma as a source of mRNA for determining IgV(H) mutation status in patients with chronic lymphocytic leukaemia.
British journal of haematology 2006;133(6):690-2.
2006: Barry D Hock; Judith L McKenzie; Nigel W Patton; Mark T Drayson; Karen Taylor; Chris Wakeman; Andrew Lamb; Francis Giles; Maher Albitar
Circulating levels and clinical significance of soluble CD40 in patients with hematologic malignancies.
Cancer 2006;106(10):2148-57.
2006: Deborah A Thomas; Francis Giles; Maher Albitar; Jorge E Cortes; Srdan Verstovsek; Stefan Faderl; Susan M O'Brien; Guillermo Garcia-Manero; Michael J Keating; Sherry Pierce; Jerome B Zeldis; Hagop M Kantarjian
Thalidomide therapy for myelofibrosis with myeloid metaplasia.
Cancer 2006;106(9):1974-84.
2006: Andrew Lamb; Jean-Pierre J Issa; Craig S Rosenfeld; John M Bennett; Maher Albitar; John DiPersio; Virginia Klimek; James Slack; Carlos de Castro; Farhad Ravandi; Richard Helmer; Lanlan Shen; Stephen D Nimer; Richard Leavitt; Azra Raza; Hussain I Saba
Decitabine improves patient outcomes in myelodysplastic syndromes: results of a phase III randomized study.
Cancer 2006;106(8):1794-803.
2006: Maher Albitar; Steven Potts; Francis Giles; Susan O'Brien; Michael Keating; Deborah Thomas; Charlotte Clarke; Iman Jilani; Christine Aguilar; Elihu Estey; Andrew Lamb
Proteomic-based prediction of clinical behavior in adult acute lymphoblastic leukemia.
Cancer 2006;106(7):1587-94.
2005: Stefan Faderl; Kim-Anh Do; Marcella M Johnson; Michael Keating; Susan O'Brien; Iman Jilani; Alessandra Ferrajoli; Farhad Ravandi-Kashani; Christine Aguilar; Amanda Dey; Deborah A Thomas; Francis Giles; Hagop M Kantarjian; Maher Albitar
Angiogenic factors may have a different prognostic role in adult acute lymphoblastic leukemia.
Blood 2005;106(13):4303-7.
2005: Susan O'Brien; Maher Albitar; Francis Giles
Monoclonal antibodies in the treatment of leukemia.
Current molecular medicine 2005;5(7):663-75.
2005: Francis Giles; Maher Albitar
Mammalian target of rapamycin as a therapeutic target in leukemia.
Current molecular medicine 2005;5(7):653-61.
2005: Francis Giles; Srdan Verstovsek; Deborah Thomas; Stanton Gerson; Jorge Cortes; Stefan Faderl; Alessandra Ferrajoli; Farhad Ravandi; Steven M Kornblau; Guillermo Garcia-Manero; Elias Jabbour; Susan O'Brien; Verena Karsten; Ann Cahill; Karen Yee; Maher Albitar; Mario Sznol; Andrew Lamb
Phase I study of cloretazine (VNP40101M), a novel sulfonylhydrazine alkylating agent, combined with cytarabine in patients with refractory leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(21):7817-24.
2005: Karen W L Yee; Anne Hagey; Srdan Verstovsek; Jorge Cortes; Guillermo Garcia-Manero; Susan M O'Brien; Stefan Faderl; Deborah Thomas; William G Wierda; Steven M Kornblau; Alessandra Ferrajoli; Maher Albitar; Evelyn McKeegan; David R Grimm; Toby Mueller; Rhonda R Holley-Shanks; Leonardo Sahelijo; Gary B Gordon; Hagop M Kantarjian; Francis Giles
Phase 1 study of ABT-751, a novel microtubule inhibitor, in patients with refractory hematologic malignancies.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(18):6615-24.
2005: Hesham M Amin; Y Yang; Yu Shen; Elihu H Estey; Francis Giles; Sherry A Pierce; Hagop M Kantarjian; Susan M O'Brien; Iman Jilani; Maher Albitar
Having a higher blast percentage in circulation than bone marrow: clinical implications in myelodysplastic syndrome and acute lymphoid and myeloid leukemias.
Leukemia 2005;19(9):1567-72.
2005: Christina A Meyers; Maher Albitar; Elihu Estey
Cognitive impairment, fatigue, and cytokine levels in patients with acute myelogenous leukemia or myelodysplastic syndrome.
Cancer 2005;104(4):788-93.
2005: Michael J Keating; Susan O'Brien; Maher Albitar; Susan Lerner; William Plunkett; Francis Giles; Michael Andreeff; Jorge Cortes; Stefan Faderl; Deborah Thomas; Charles Koller; William G Wierda; Michelle A Detry; Alice Lynn; Andrew Lamb
Early results of a chemoimmunotherapy regimen of fludarabine, cyclophosphamide, and rituximab as initial therapy for chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4079-88.
2005: William G Wierda; Susan O'Brien; Sijin Wen; Stefan Faderl; Guillermo Garcia-Manero; Deborah Thomas; Kim-Anh Do; Jorge Cortes; Charles Koller; Miloslav Beran; Alessandra Ferrajoli; Francis Giles; Susan Lerner; Maher Albitar; Andrew Lamb; Michael Keating
Chemoimmunotherapy with fludarabine, cyclophosphamide, and rituximab for relapsed and refractory chronic lymphocytic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(18):4070-8.
2005: Francis Giles; Hagop M Kantarjian; Jorge E Cortes; Stefan Faderl; Srdan Verstovsek; Deborah Thomas; Guillermo Garcia-Manero; William G Wierda; Alessandra Ferrajoli; Steven M Kornblau; Gloria N Mattiuzzi; Apostolia-Maria Tsimberidou; Maher Albitar; Susan M O'Brien; Elihu Estey
Adaptive randomized study of idarubicin and cytarabine alone or with interleukin-11 as induction therapy in patients aged 50 or above with acute myeloid leukemia or high-risk myelodysplastic syndromes.
Leukemia research 2005;29(6):649-52.
2004: Iman Jilani; Michael Keating; Francis Giles; Susan O'Brien; Hagop M Kantarjian; Maher Albitar
Alemtuzumab: validation of a sensitive and simple enzyme-linked immunosorbent assay.
Leukemia research 2004;28(12):1255-62.
2004: Maher Albitar; Kim-Anh Do; Marcella M Johnson; Francis Giles; Iman Jilani; Susan O'Brien; Jorge Cortes; Deborah Thomas; Laura Rassenti; Thomas Kipps; Hagop M Kantarjian; Michael Keating
Free circulating soluble CD52 as a tumor marker in chronic lymphocytic leukemia and its implication in therapy with anti-CD52 antibodies.
Cancer 2004;101(5):999-1008.
2004: Srdan Verstovsek; Francis Giles; Susan O'Brien; Stefan Faderl; Hagop M Kantarjian; Michael J Keating; Maher Albitar
Telomerase activity is not a prognostic factor in chronic lymphocytic leukemia.
Leukemia research 2004;28(7):707-11.
2004: Anne-Marie O'Farrell; Helene A Yuen; Beverly D Smolich; Alison L Hannah; Sharianne G Louie; Weiru Hong; Alison T Stopeck; Lewis R Silverman; Jeffrey E Lancet; Judith E Karp; Maher Albitar; Julie M Cherrington; Francis Giles
Effects of SU5416, a small molecule tyrosine kinase receptor inhibitor, on FLT3 expression and phosphorylation in patients with refractory acute myeloid leukemia.
Leukemia research 2004;28(7):679-89.
2004: Francis Giles; Julie M Vose; Kim-Anh Do; Marcella M Johnson; Taghi Manshouri; Gregory Bociek; Philip J Bierman; Susan M O'Brien; Hagop M Kantarjian; James O Armitage; Maher Albitar
Clinical relevance of circulating angiogenic factors in patients with non-Hodgkin's lymphoma or Hodgkin's lymphoma.
Leukemia research 2004;28(6):595-604.
2004: Yupo Ma; Adnan Mansour; B Nebiyou Bekele; Xian Zhou; Michael J Keating; Susan O'Brien; Francis Giles; Maher Albitar
The clinical significance of large cells in bone marrow in patients with chronic lymphocytic leukemia.
Cancer 2004;100(10):2167-75.
2004: Qinglong Hu; Amanda L Dey; Ying Yang; Yu Shen; Iman Jilani; Elihu H Estey; Hagop M Kantarjian; Francis Giles; Maher Albitar
Soluble vascular endothelial growth factor receptor 1, and not receptor 2, is an independent prognostic factor in acute myeloid leukemia and myelodysplastic syndromes.
Cancer 2004;100(9):1884-91.
2004: Maher Albitar; Weidong Zhou; Francis Giles
Myelodysplastic syndrome: from morphology to biology.
Current hematology reports 2004;3(3):159-64.
2004: Anne S Tsao; Andrew Lamb; Deborah Thomas; Francis Giles; Jorge Cortes; Guillermo Garcia-Manero; Yang Huh; Ying Yang; Yu Shen; Maher Albitar; Elihu Estey
C-kit receptor expression in acute leukemias-association with patient and disease characteristics and with outcome.
Leukemia research 2004;28(4):373-8.
2004: Razelle Kurzrock; Maher Albitar; Jorge E Cortes; Elihu H Estey; Stefan Faderl; Guillermo Garcia-Manero; Deborah A Thomas; Francis Giles; Mary Ellen Ryback; Alain Thibault; P De Porre; Hagop M Kantarjian
Phase II study of R115777, a farnesyl transferase inhibitor, in myelodysplastic syndrome.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2004;22(7):1287-92.
2004: Francis Giles; Martin S Tallman; Guillermo Garcia-Manero; Jorge E Cortes; Deborah A Thomas; William G Wierda; Srdan Verstovsek; Marta Hamilton; Emma Barrett; Maher Albitar; Hagop M Kantarjian
Phase I and pharmacokinetic study of a low-clearance, unilamellar liposomal formulation of lurtotecan, a topoisomerase 1 inhibitor, in patients with advanced leukemia.
Cancer 2004;100(7):1449-58.
2004: Issa F Khouri; Maher Albitar; Rima M Saliba; Cindy Ippoliti; Y C Ma; Michael J Keating; Richard E Champlin
Low-dose alemtuzumab (Campath) in myeloablative allogeneic stem cell transplantation for CD52-positive malignancies: decreased incidence of acute graft-versus-host-disease with unique pharmacokinetics.
Bone marrow transplantation 2004;33(8):833-7.
2004: Anna Rogers; Youngson Joe; Taghi Manshouri; Amanda Dey; Iman Jilani; Francis Giles; Elihu Estey; Emil J Freireich; Michael Keating; Andrew Lamb; Maher Albitar
Relative increase in leukemia-specific DNA in peripheral blood plasma from patients with acute myeloid leukemia and myelodysplasia.
Blood 2004;103(7):2799-801.
2004: Barbara Pro; Anas Younes; Maher Albitar; Nam H Dang; Felipe Samaniego; Jorge Romaguera; Peter McLaughlin; Fredrick B Hagemeister; Maria A Rodriguez; Marilyn Clemons; Fernando Cabanillas
Thalidomide for patients with recurrent lymphoma.
Cancer 2004;100(6):1186-9.
2004: Elizabeth O Hileman; Jinsong Liu; Maher Albitar; Michael J Keating; Peng Huang
Intrinsic oxidative stress in cancer cells: a biochemical basis for therapeutic selectivity.
Cancer chemotherapy and pharmacology 2004;53(3):209-19.
2004: Nicholas J Donato; Ji Y Wu; Jonathan Stapley; Hui Lin; Ralph B Arlinghaus; Bharat B Aggarwal; Shishir Shishodia; Maher Albitar; Kimberly Hayes; Andrew Lamb; Moshe Talpaz; Shishir Shishodin
Imatinib mesylate resistance through BCR-ABL independence in chronic myelogenous leukemia.
Cancer research 2004;64(2):672-7.
2004: Maurizio Zangari; Elias Anaissie; Alison T Stopeck; Alyssa Morimoto; Nguyen Tan; Jeffrey E Lancet; Maureen Cooper; Alison L Hannah; Guillermo Garcia-Manero; Stefan Faderl; Andrew Lamb; Julie M Cherrington; Maher Albitar; Francis Giles
Phase II study of SU5416, a small molecule vascular endothelial growth factor tyrosine kinase receptor inhibitor, in patients with refractory multiple myeloma.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(1 Pt 1):88-95.
2004: Pei Lin; Lois Lucas; Cheryl Ginsberg; Maher Albitar
Bovine serum albumin in the preparation of peripheral blood smears.
Cytometry. Part B, Clinical cytometry 2004;57(1):53-4.
2003: Susan M O'Brien; Hagop M Kantarjian; Deborah A Thomas; Jorge Cortes; Francis Giles; William G Wierda; Charles Koller; Alessandra Ferrajoli; Mary L Browning; Susan Lerner; Maher Albitar; Michael J Keating
Alemtuzumab as treatment for residual disease after chemotherapy in patients with chronic lymphocytic leukemia.
Cancer 2003;98(12):2657-63.
2003: Francis Giles; Julie M Vose; Kim-Anh Do; Marcella M Johnson; Taghi Manshouri; Gregory Bociek; Philip J Bierman; Susan M O'Brien; Michael J Keating; Hagop M Kantarjian; James O Armitage; Maher Albitar
Circulating CD20 and CD52 in patients with non-Hodgkin's lymphoma or Hodgkin's disease.
British journal of haematology 2003;123(5):850-7.
2003: Francis Giles; Eric J Feldman; Gail J Roboz; Richard A Larson; Steven W Mamus; Jorge E Cortes; Srdan Verstovsek; Stefan Faderl; Moshe Talpaz; Miloslav Beran; Maher Albitar; Susan M O'Brien; Hagop M Kantarjian
Phase II study of troxacitabine, a novel dioxolane nucleoside analog, in patients with untreated or imatinib mesylate-resistant chronic myelogenous leukemia in blastic phase.
Leukemia research 2003;27(12):1091-6.
2003: Iman Jilani; Susan O'Brien; Taghi Manshuri; Deborah A Thomas; Vilmos A Thomazy; Maha Imam; Sana Naeem; Srdan Verstovsek; Andrew Lamb; Francis Giles; Michael Keating; Maher Albitar
Transient down-modulation of CD20 by rituximab in patients with chronic lymphocytic leukemia.
Blood 2003;102(10):3514-20.
2003: Deborah A Thomas; Elihu Estey; Francis Giles; Stefan Faderl; Jorge Cortes; Michael Keating; Susan O'Brien; Maher Albitar; Andrew Lamb
Single agent thalidomide in patients with relapsed or refractory acute myeloid leukaemia.
British journal of haematology 2003;123(3):436-41.
2003: Barry D Hock; Judith L McKenzie; William Nigel Patton; Lisa F Haring; Ying Yang; Yu Shen; Elihu H Estey; Maher Albitar
The clinical significance of soluble CD86 levels in patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer 2003;98(8):1681-8.
2003: Jeong N Lee; Francis Giles; Yang O Huh; Taghi Manshouri; Susan O'Brien; Hagop M Kantarjian; Michael J Keating; Maher Albitar
Molecular differences between small and large cells in patients with chronic lymphocytic leukemia.
European journal of haematology 2003;71(4):235-42.
2003: Naoko Ishibe; Lynn R Goldin; Neil E Caporaso; Maria Sgambati; Michael Dean; Maher Albitar; Taghi Manshouri; Bernard Gerrard; Gerald E Marti
ATM mutations and protein expression are not associated with familial B-CLL cases.
Leukemia research 2003;27(10):973-5.
2003: Apostolia-Maria Tsimberidou; Jorge Cortes; Deborah Thomas; Guillermo Garcia-Manero; Srdan Verstovsek; Stefan Faderl; Maher Albitar; Andrew Lamb; Elihu Estey; Francis Giles
Gemtuzumab ozogamicin, fludarabine, cytarabine and cyclosporine combination regimen in patients with CD33+ primary resistant or relapsed acute myeloid leukemia.
Leukemia research 2003;27(10):893-7.
2003: Maha Ahmed; Francis Giles; Youngson Joe; Donna M Weber; Iman Jilani; Taghi Manshouri; Sergio Giralt; Marcos De Lima; Michael Keating; Maher Albitar
Use of plasma DNA in detection of loss of heterozygosity in patients with multiple myeloma.
European journal of haematology 2003;71(3):174-8.
2003: Apostolia-Maria Tsimberidou; Dawn E Colburn; Mary Alma Welch; Jorge E Cortes; Srdan Verstovsek; Susan M O'Brien; Maher Albitar; Hagop M Kantarjian; Francis Giles
Anagrelide and imatinib mesylate combination therapy in patients with chronic myeloproliferative disorders.
Cancer chemotherapy and pharmacology 2003;52(3):229-34.
2003: Hesham M Amin; Iman Jilani; Elihu H Estey; Michael J Keating; Amanda L Dey; Taghi Manshouri; Hagop M Kantarjian; Zeev Estrov; Jorge E Cortes; Deborah A Thomas; Francis Giles; Maher Albitar
Increased apoptosis in bone marrow B lymphocytes but not T lymphocytes in myelodysplastic syndrome.
Blood 2003;102(5):1866-8.
2003: Francis Giles; Alison T Stopeck; Lewis R Silverman; Jeffrey E Lancet; Maureen A Cooper; Alison L Hannah; Julie M Cherrington; Anne-Marie O'Farrell; Helene A Yuen; Sharianne G Louie; Weiru Hong; Jorge E Cortes; Srdan Verstovsek; Maher Albitar; Susan M O'Brien; Hagop M Kantarjian; Judith E Karp
SU5416, a small molecule tyrosine kinase receptor inhibitor, has biologic activity in patients with refractory acute myeloid leukemia or myelodysplastic syndromes.
Blood 2003;102(3):795-801.
2003: Srdan Verstovsek; Scott Lunin; Andrew Lamb; Taghi Manshouri; Stefan Faderl; Jorge Cortes; Francis Giles; Maher Albitar
Clinical relevance of VEGF receptors 1 and 2 in patients with chronic myelogenous leukemia.
Leukemia research 2003;27(7):661-9.
2003: Jorge Cortes; Francis Giles; Susan O'Brien; Deborah Thomas; Maher Albitar; Mary Beth Rios; Moshe Talpaz; Guillermo Garcia-Manero; Stefan Faderl; Laurie Letvak; August Salvado; Andrew Lamb
Results of imatinib mesylate therapy in patients with refractory or recurrent acute myeloid leukemia, high-risk myelodysplastic syndrome, and myeloproliferative disorders.
Cancer 2003;97(11):2760-6.
2003: Apostolia-Maria Tsimberidou; Hagop M Kantarjian; Elihu Estey; Jorge E Cortes; Srdan Verstovsek; Stefan Faderl; D A Thomas; Guillermo Garcia-Manero; Alessandra Ferrajoli; John T Manning; Michael J Keating; Maher Albitar; Susan O'Brien; Francis Giles
Outcome in patients with nonleukemic granulocytic sarcoma treated with chemotherapy with or without radiotherapy.
Leukemia 2003;17(6):1100-3.
2003: Francis Giles; B Nebiyou Bekele; Susan O'Brien; Jorge E Cortes; Srdan Verstovsek; Maria Balerdi; Marwan Yared; Xian Zhou; Hagop M Kantarjian; Michael J Keating; Peter F Thall; Maher Albitar
A prognostic model for survival in chronic lymphocytic leukaemia based on p53 expression.
British journal of haematology 2003;121(4):578-85.
2003: Hatice Duzkale; Iman Jilani; Nada Orsolic; Ralph A Zingaro; Mirna Golemovic; Francis Giles; Andrew Lamb; Maher Albitar; Emil J Freireich; Srdan Verstovsek
In vitro activity of dimethylarsinic acid against human leukemia and multiple myeloma cell lines.
Cancer chemotherapy and pharmacology 2003;51(5):427-32.
2003: Srdan Verstovsek; Taghi Manshouri; Franklin O Smith; Francis Giles; Jorge Cortes; Elihu Estey; Andrew Lamb; Michael Keating; Sima Jeha; Maher Albitar
Telomerase activity is prognostic in pediatric patients with acute myeloid leukemia: comparison with adult acute myeloid leukemia.
Cancer 2003;97(9):2212-7.
2003: Apostolia-Maria Tsimberidou; Tracey A Waddelow; Hagop M Kantarjian; Maher Albitar; Francis Giles
Pilot study of recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein (TNFR:Fc; Enbrel) in patients with refractory multiple myeloma: increase in plasma TNF alpha levels during treatment.
Leukemia research 2003;27(5):375-80.
2003: Francis Giles; Maureen A Cooper; Lewis Silverman; Judith E Karp; Jeffrey E Lancet; Maurizio Zangari; Paul J Shami; Khuda Dad Khan; Alison L Hannah; Julie M Cherrington; Deborah A Thomas; Guillermo Garcia-Manero; Maher Albitar; Hagop M Kantarjian; Alison T Stopeck
Phase II study of SU5416--a small-molecule, vascular endothelial growth factor tyrosine-kinase receptor inhibitor--in patients with refractory myeloproliferative diseases.
Cancer 2003;97(8):1920-8.
2003: Sherif Ibrahim; Iman Jilani; Susan O'Brien; Anna Rogers; Taghi Manshouri; Francis Giles; Stefan Faderl; Deborah Thomas; Andrew Lamb; Michael Keating; Maher Albitar
Clinical relevance of the expression of the CD31 ligand for CD38 in patients with B-cell chronic lymphocytic leukemia.
Cancer 2003;97(8):1914-9.
2003: Apostolia-Maria Tsimberidou; Hagop M Kantarjian; Jorge Cortes; Deborah A Thomas; Stefan Faderl; Guillermo Garcia-Manero; Srdan Verstovsek; Alessandra Ferrajoli; William G Wierda; Yesid Alvarado; Susan M O'Brien; Maher Albitar; Michael J Keating; Francis Giles
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin, and dexamethasone plus rituximab and granulocyte-macrophage-colony stimulating factor (GM-CSF) alternating with methotrexate and cytarabine plus rituximab and GM-CSF in patients with Richter syndrome or fludarabine-refractory chronic lymphocytic leukemia.
Cancer 2003;97(7):1711-20.
2003: Taghi Manshouri; Kim-Anh Do; Xuemei Wang; Francis Giles; Susan M O'Brien; Helene Saffer; Deborah Thomas; Iman Jilani; Hagop M Kantarjian; Michael J Keating; Maher Albitar
Circulating CD20 is detectable in the plasma of patients with chronic lymphocytic leukemia and is of prognostic significance.
Blood 2003;101(7):2507-13.
2003: Apostolia-Maria Tsimberidou; Elihu Estey; Jorge Cortes; Deborah Thomas; Stefan Faderl; Srdan Verstovsek; Guillermo Garcia-Manero; Michael Keating; Maher Albitar; Susan O'Brien; Andrew Lamb; Francis Giles
Gemtuzumab, fludarabine, cytarabine, and cyclosporine in patients with newly diagnosed acute myelogenous leukemia or high-risk myelodysplastic syndromes.
Cancer 2003;97(6):1481-7.
2003: Srdan Verstovsek; Andrew Lamb; Taghi Manshouri; Jorge Cortes; Stefan Faderl; Francis Giles; Michael Keating; Maher Albitar
Increased telomerase activity is associated with shorter survival in patients with chronic phase chronic myeloid leukemia.
Cancer 2003;97(5):1248-52.
2003: Jorge Cortes; Andrew Lamb; Maher Albitar; Deborah Thomas; Stefan Faderl; Charles Koller; Guillermo Garcia-Manero; Francis Giles; Michael Andreeff; Susan O'Brien; Michael Keating; Elihu Estey
A randomized trial of liposomal daunorubicin and cytarabine versus liposomal daunorubicin and topotecan with or without thalidomide as initial therapy for patients with poor prognosis acute myelogenous leukemia or myelodysplastic syndrome.
Cancer 2003;97(5):1234-41.
2003: Jorge Cortes; Maher Albitar; Deborah Thomas; Francis Giles; Razelle Kurzrock; Alain Thibault; Wayne Rackoff; Charles Koller; Susan O'Brien; Guillermo Garcia-Manero; Moshe Talpaz; Andrew Lamb
Efficacy of the farnesyl transferase inhibitor R115777 in chronic myeloid leukemia and other hematologic malignancies.
Blood 2003;101(5):1692-7.
2003: Alvaro Aguayo; Francis Giles; Maher Albitar
Vascularity, angiogenesis and angiogenic factors in leukemias and myelodysplastic syndromes.
Leukemia & lymphoma 2003;44(2):213-22.
2003: William G Wierda; Marcella M Johnson; Kim-Anh Do; Taghi Manshouri; Amanda Dey; Susan O'Brien; Francis Giles; Andrew Lamb; Deborah Thomas; Stefan Faderl; Susan Lerner; Michael Keating; Maher Albitar
Plasma interleukin 8 level predicts for survival in chronic lymphocytic leukaemia.
British journal of haematology 2003;120(3):452-6.
2003: Guillermo Garcia-Manero; Sima Jeha; Jerry Daniel; Jason Williamson; Maher Albitar; Hagop M Kantarjian; Jean-Pierre J Issa
Aberrant DNA methylation in pediatric patients with acute lymphocytic leukemia.
Cancer 2003;97(3):695-702.
2003: Di Lu; Randa Nounou; Miloslav Beran; Elihu Estey; Taghi Manshouri; Andrew Lamb; Michael J Keating; Maher Albitar
The prognostic significance of bone marrow levels of neurofibromatosis-1 protein and ras oncogene mutations in patients with acute myeloid leukemia and myelodysplastic syndrome.
Cancer 2003;97(2):441-9.
2003: Chung-Wu Lin; Jia-Ying Yang; Yi-Chun Chuang; Yu-Hua Chen; Maher Albitar; Su-Ming Hsu
Presence of restricted killer immunoglobulin-like receptor repertoire and monoclonal T-cell receptor gamma rearrangement as evidence of mixed NK/T-cell differentiation in a subset of sinonasal lymphomas.
Laboratory investigation; a journal of technical methods and pathology 2003;83(1):55-64.
2003: Iman Jilani; Elihu Estey; T Manshuri; M Caligiuri; Michael Keating; Francis Giles; Deborah Thomas; Andrew Lamb; Maher Albitar
Better detection of FLT3 internal tandem duplication using peripheral blood plasma DNA.
Leukemia 2003;17(1):114-9.
2002: Filiz Sen; Raymond Lai; Maher Albitar
Chronic lymphocytic leukemia with t(14;18) and trisomy 12.
Archives of pathology & laboratory medicine 2002;126(12):1543-6.
2002: Alvaro Aguayo; Hagop M Kantarjian; Elihu H Estey; Francis Giles; Srdan Verstovsek; Taghi Manshouri; Christy Gidel; Susan O'Brien; Michael J Keating; Maher Albitar
Plasma vascular endothelial growth factor levels have prognostic significance in patients with acute myeloid leukemia but not in patients with myelodysplastic syndromes.
Cancer 2002;95(9):1923-30.
2002: Yang O Huh; Iman Jilani; Elihu Estey; Francis Giles; Andrew Lamb; Emil J Freireich; Maher Albitar
More cell death in refractory anemia with excess blasts in transformation than in acute myeloid leukemia.
Leukemia 2002;16(11):2249-52.
2002: Francesco Onida; Greg Ball; Hagop M Kantarjian; Terry L Smith; Armand B. Glassman; Maher Albitar; Barbara Scappini; Mary Beth Rios; Michael J Keating; Miloslav Beran
Characteristics and outcome of patients with Philadelphia chromosome negative, bcr/abl negative chronic myelogenous leukemia.
Cancer 2002;95(8):1673-84.
2002: Christina A Meyers; Lee F Seabrooke; Maher Albitar; Elihu H Estey
Association of cancer-related symptoms with physiological parameters.
Journal of pain and symptom management 2002;24(4):359-61.
2002: Iman Jilani; Elihu Estey; Yang Huh; Youngson Joe; Taghi Manshouri; Marwan Yared; Francis Giles; Andrew Lamb; Jorge Cortes; Deborah Thomas; Michael Keating; Emil J Freireich; Maher Albitar
Differences in CD33 intensity between various myeloid neoplasms.
American journal of clinical pathology 2002;118(4):560-6.
2002: Francis Giles; Hagop M Kantarjian; B Nebiyou Bekele; Jorge E Cortes; Stefan Faderl; Deborah A Thomas; Taghi Manshouri; Anna Rogers; Michael J Keating; Moshe Talpaz; Susan O'Brien; Maher Albitar
Bone marrow cyclooxygenase-2 levels are elevated in chronic-phase chronic myeloid leukaemia and are associated with reduced survival.
British journal of haematology 2002;119(1):38-45.
2002: LaBaron T Washington; Iman Jilani; Elihu Estey; Maher Albitar
Less apoptosis in patients with 5q-syndrome than in patients with refractory anemia.
Leukemia research 2002;26(10):899-902.
2002: Issam Raad; Jeffrey J Tarrand; Hend Hanna; Maher Albitar; Erle Janssen; Maha Boktour; Gerald P Bodey; Masoud Mardani; Ray Hachem; Dimitrios P Kontoyiannis; Estella E Whimbey; Kenneth Rolston
Epidemiology, molecular mycology, and environmental sources of Fusarium infection in patients with cancer.
Infection control and hospital epidemiology : the official journal of the Society of Hospital Epidemiologists of America 2002;23(9):532-7.
2002: Raymond Lai; Susan O'Brien; Taghi Maushouri; Anna Rogers; Andrew Lamb; Michael Keating; Maher Albitar
Prognostic value of plasma interleukin-6 levels in patients with chronic lymphocytic leukemia.
Cancer 2002;95(5):1071-5.
2002: Apostolia-Maria Tsimberidou; Deborah Thomas; Susan O'Brien; Michael Andreeff; Razelle Kurzrock; Michael Keating; Maher Albitar; Andrew Lamb; Francis Giles
Recombinant human soluble tumor necrosis factor (TNF) receptor (p75) fusion protein Enbrel in patients with refractory hematologic malignancies.
Cancer chemotherapy and pharmacology 2002;50(3):237-42.
2002: Alessandra Ferrajoli; Michael J Keating; Taghi Manshouri; Francis Giles; Amanda Dey; Zeev Estrov; Charles Koller; Razelle Kurzrock; Deborah A Thomas; Stefan Faderl; Susan Lerner; Susan O'Brien; Maher Albitar
The clinical significance of tumor necrosis factor-alpha plasma level in patients having chronic lymphocytic leukemia.
Blood 2002;100(4):1215-9.
2002: Naoko Ishibe; Maher Albitar; Iman Jilani; Lynn R Goldin; Gerald E Marti; Neil E Caporaso
CXCR4 expression is associated with survival in familial chronic lymphocytic leukemia, but CD38 expression is not.
Blood 2002;100(3):1100-1.
2002: Maher Albitar; Taghi Manshouri; Yu Shen; Diane Liu; Miloslav Beran; Hagop M Kantarjian; Anna Rogers; Iman Jilani; Chung-Wu Lin; Sherry Pierce; Emil J Freireich; Elihu H Estey
Myelodysplastic syndrome is not merely "preleukemia".
Blood 2002;100(3):791-8.
2002: Hagop M Kantarjian; Moshe Talpaz; Susan O'Brien; Terry L Smith; Francis Giles; Stefan Faderl; Deborah A Thomas; Guillermo Garcia-Manero; Jean-Pierre J Issa; Michael Andreeff; Steven M Kornblau; Charles Koller; Miloslav Beran; Michael Keating; Mary Beth Rios; Jianqin Shan; Debra Resta; Renaud Capdeville; Kimberly Hayes; Maher Albitar; Emil J Freireich; Jorge E Cortes
Imatinib mesylate for Philadelphia chromosome-positive, chronic-phase myeloid leukemia after failure of interferon-alpha: follow-up results.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(7):2177-87.
2002: Srdan Verstovsek; Elihu Estey; Taghi Manshouri; Francis Giles; Jorge Cortes; Miloslav Beran; Anna Rogers; Michael Keating; Andrew Lamb; Maher Albitar
Clinical relevance of vascular endothelial growth factor receptors 1 and 2 in acute myeloid leukaemia and myelodysplastic syndrome.
British journal of haematology 2002;118(1):151-6.
2002: Stefan Faderl; Michael J Keating; Kim-Anh Do; S-Y Liang; Hagop M Kantarjian; Susan O'Brien; Guillermo Garcia-Manero; Taghi Manshouri; Maher Albitar
Expression profile of 11 proteins and their prognostic significance in patients with chronic lymphocytic leukemia (CLL).
Leukemia 2002;16(6):1045-52.
2002: Chung-Wu Lin; Taghi Manshouri; Iman Jilani; Donna Neuberg; Kunal Patel; Andrew Lamb; Michael Andreeff; Zeev Estrov; Miloslav Beran; Michael Keating; Elihu Estey; Maher Albitar
Proliferation and apoptosis in acute and chronic leukemias and myelodysplastic syndrome.
Leukemia research 2002;26(6):551-9.
2002: Michael J Keating; Ian W Flinn; Vinay Jain; Jacques-Louis Binet; Peter Hillmen; John Byrd; Maher Albitar; Lee R Brettman; Pedro Santabarbara; Bret Wacker; Kanti Rai
Therapeutic role of alemtuzumab (Campath-1H) in patients who have failed fludarabine: results of a large international study.
Blood 2002;99(10):3554-61.
2002: Hagop M Kantarjian; Jorge Cortes; Susan O'Brien; Francis Giles; Maher Albitar; Mary Beth Rios; Jianqin Shan; Stefan Faderl; Guillermo Garcia-Manero; Deborah A Thomas; Debra Resta; Moshe Talpaz
Imatinib mesylate (STI571) therapy for Philadelphia chromosome-positive chronic myelogenous leukemia in blast phase.
Blood 2002;99(10):3547-53.
2002: R Oudat; Michael J Keating; Susan Lerner; Susan O'Brien; Maher Albitar
Significance of the levels of bone marrow lymphoid infiltrate in chronic lymphocytic leukemia patients with nodular partial remission.
Leukemia 2002;16(4):632-5.
2002: Issam Raad; Hend Hanna; Armando Huaringa; David Sumoza; Ray Hachem; Maher Albitar
Diagnosis of invasive pulmonary aspergillosis using polymerase chain reaction-based detection of aspergillus in BAL.
Chest 2002;121(4):1171-6.
2002: Sima Jeha; Franklin O Smith; Elihu Estey; Yu Shen; Diane Liu; Taghi Manshouri; Maher Albitar
Comparison between pediatric acute myeloid leukemia (AML) and adult AML in VEGF and KDR (VEGF-R2) protein levels.
Leukemia research 2002;26(4):399-402.
2002: Francesco DiRaimondo; Maher Albitar; Yang Huh; Susan O'Brien; Marco Montillo; Alessandra Tedeschi; Andrew Lamb; Susan Lerner; Rosario Giustolisi; Michael Keating
The clinical and diagnostic relevance of CD23 expression in the chronic lymphoproliferative disease.
Cancer 2002;94(6):1721-30.
2002: Srdan Verstovsek; Andrew Lamb; Taghi Manshouri; Jorge Cortes; Francis Giles; Anna Rogers; Maher Albitar
Prognostic significance of cellular vascular endothelial growth factor expression in chronic phase chronic myeloid leukemia.
Blood 2002;99(6):2265-7.
2002: Martin Körbling; Ruth Katz; Abha Khanna; Arnout C Ruifrok; Gabriela Rondon; Maher Albitar; Richard E Champlin; Zeev Estrov
Hepatocytes and epithelial cells of donor origin in recipients of peripheral-blood stem cells.
The New England journal of medicine 2002;346(10):738-46.
2002: Srdan Verstovsek; Andrew Lamb; Taghi Manshouri; Susan O'Brien; Stefan Faderl; Moshe Talpaz; Jorge Cortes; Maher Albitar
Prognostic significance of Tie-1 protein expression in patients with early chronic phase chronic myeloid leukemia.
Cancer 2002;94(5):1517-21.
2002: Issam Raad; Hend Hanna; David Sumoza; Maher Albitar
Polymerase chain reaction on blood for the diagnosis of invasive pulmonary aspergillosis in cancer patients.
Cancer 2002;94(4):1032-6.
2002: Michael J Keating; Susan O'Brien; Maher Albitar
Emerging information on the use of rituximab in chronic lymphocytic leukemia.
Seminars in oncology 2002;29(1 Suppl 2):70-4.
2002: Francesco Onida; Hagop M Kantarjian; Terry L Smith; Greg Ball; Michael J Keating; Elihu H Estey; Armand B. Glassman; Maher Albitar; Monica Kwari; Miloslav Beran
Prognostic factors and scoring systems in chronic myelomonocytic leukemia: a retrospective analysis of 213 patients.
Blood 2002;99(3):840-9.
2002: Raymond Lai; Elihu Estey; Yu Shen; Simona Despa; Andrew Lamb; Miloslav Beran; Taghi Maushouri; Robert C Quackenbuch; Michael Keating; Maher Albitar
Clinical significance of plasma endostatin in acute myeloid leukemia/myelodysplastic syndrome.
Cancer 2002;94(1):14-7.
2001: Maher Albitar; Taghi Manshouri; Christy Gidel; Carlo M Croce; Steven M Kornblau; Sherry Pierce; Hagop M Kantarjian
Clinical significance of fragile histidine triad gene expression in adult acute lymphoblastic leukemia.
Leukemia research 2001;25(10):859-64.
2001: R Aboul-Nasr; Susan O'Brien; Emil J Freireich; C F Ginsberg; Hagop M Kantarjian; Charles Koller; Michael J Keating; Maher Albitar
"T-cell-rich B-cell lymphoproliferative disorder" of the bone marrow.
Leukemia & lymphoma 2001;42(5):1023-31.
2001: Yang O Huh; Michael J Keating; Helene Saffer; Iman Jilani; Susan Lerner; Maher Albitar
Higher levels of surface CD20 expression on circulating lymphocytes compared with bone marrow and lymph nodes in B-cell chronic lymphocytic leukemia.
American journal of clinical pathology 2001;116(3):437-43.
2001: Srdan Verstovsek; Andrew Lamb; Alvaro Aguayo; Taghi Manshouri; Emil J Freireich; Michael Keating; Elihu Estey; Maher Albitar
Significance of angiogenin plasma concentrations in patients with acute myeloid leukaemia and advanced myelodysplastic syndrome.
British journal of haematology 2001;114(2):290-5.
2001: Srdan Verstovsek; Andrew Lamb; Elihu Estey; Alvaro Aguayo; Francis Giles; Taghi Manshouri; Charles Koller; Zeev Estrov; Emil J Freireich; Michael Keating; Maher Albitar
Plasma hepatocyte growth factor is a prognostic factor in patients with acute myeloid leukemia but not in patients with myelodysplastic syndrome.
Leukemia 2001;15(8):1165-70.
2001: Srdan Verstovsek; Elihu Estey; Taghi Manshouri; Michael Keating; Andrew Lamb; Francis Giles; Maher Albitar
High expression of the receptor tyrosine kinase Tie-1 in acute myeloid leukemia and myelodysplastic syndrome.
Leukemia & lymphoma 2001;42(3):511-6.
2001: Bouthaina S Dabaja; Susan M O'Brien; Hagop M Kantarjian; Jorge E Cortes; Deborah A Thomas; Maher Albitar; E S Schlette; Stefan Faderl; Andreas H Sarris; Michael J Keating; Francis Giles
Fractionated cyclophosphamide, vincristine, liposomal daunorubicin (daunoXome), and dexamethasone (hyperCVXD) regimen in Richter's syndrome.
Leukemia & lymphoma 2001;42(3):329-37.
2001: S Ibrahim; Michael Keating; Kim-Anh Do; Susan O'Brien; Yang O Huh; Iman Jilani; Susan Lerner; Hagop M Kantarjian; Maher Albitar
CD38 expression as an important prognostic factor in B-cell chronic lymphocytic leukemia.
Blood 2001;98(1):181-6.
2001: Farhad Ravandi; Hagop M Kantarjian; Moshe Talpaz; Susan O'Brien; Stefan Faderl; Francis Giles; Deborah Thomas; Jorge Cortes; Michael Andreeff; Zeev Estrov; Mary Beth Rios; Maher Albitar
Expression of apoptosis proteins in chronic myelogenous leukemia: associations and significance.
Cancer 2001;91(11):1964-72.
2001: Farhad Ravandi; Kimberly Hayes; Jorge Cortes; Maher Albitar; Armand B. Glassman; Moshe Talpaz; Hagop M Kantarjian
Translocation t(17;18)(q10;q10): a new nonrandom chromosomal translocation of clonal evolution in chronic myeloid leukemia.
Cancer 2001;91(9):1704-8.
2001: Alessandra Ferrajoli; Taghi Manshouri; Zeev Estrov; Michael J Keating; Susan O'Brien; Susan Lerner; Miloslav Beran; Hagop M Kantarjian; Emil J Freireich; Maher Albitar
High levels of vascular endothelial growth factor receptor-2 correlate with shortened survival in chronic lymphocytic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2001;7(4):795-9.
2001: Alvaro Aguayo; Taghi Manshouri; Susan O'Brien; Michael Keating; Miloslav Beran; Charles Koller; Andrew Lamb; Anna Rogers; Maher Albitar
Clinical relevance of Flt1 and Tie1 angiogenesis receptors expression in B-cell chronic lymphocytic leukemia (CLL).
Leukemia research 2001;25(4):279-85.
2001: Beverly D Smolich; Helene A Yuen; K A West; Francis Giles; Maher Albitar; Julie M Cherrington
The antiangiogenic protein kinase inhibitors SU5416 and SU6668 inhibit the SCF receptor (c-kit) in a human myeloid leukemia cell line and in acute myeloid leukemia blasts.
Blood 2001;97(5):1413-21.
2001: J E Sarriera; Maher Albitar; Zeev Estrov; Christy Gidel; R Aboul-Nasr; Taghi Manshouri; Steven M Kornblau; Kun-Sang Chang; Andrew Lamb; Elihu Estey
Comparison of outcome in acute myelogenous leukemia patients with translocation (8;21) found by standard cytogenetic analysis and patients with AML1/ETO fusion transcript found only by PCR testing.
Leukemia 2001;15(1):57-61.
2001: Stefan Faderl; Christy Gidel; Hagop M Kantarjian; Taghi Manshouri; Michael Keating; Maher Albitar
Loss of heterozygosity on chromosome 5 in adults with acute lymphoblastic leukemia.
Leukemia research 2001;25(1):39-43.
2000: Stefan Faderl; Maher Albitar
Insights into the biologic and molecular abnormalities in adult acute lymphocytic leukemia.
Hematology/oncology clinics of North America 2000;14(6):1267-88.
2000: Sima Jeha; Ka Wah Chan; Andrew A G Aprikyan; W Keith Hoots; SJ Culbert; Hallie Zietz; David C Dale; Maher Albitar
Spontaneous remission of granulocyte colony-stimulating factor-associated leukemia in a child with severe congenital neutropenia.
Blood 2000;96(10):3647-9.
2000: S Ibrahim; Elihu H Estey; Sherry Pierce; Armand B. Glassman; Michael Keating; Susan O'Brien; Hagop M Kantarjian; Maher Albitar
11q23 abnormalities in patients with acute myelogenous leukemia and myelodysplastic syndrome as detected by molecular and cytogenetic analyses.
American journal of clinical pathology 2000;114(5):793-7.
2000: Stefan Faderl; Hagop M Kantarjian; Elihu Estey; Taghi Manshouri; C Y Chan; A Rahman Elsaied; Steven M Kornblau; Jorge Cortes; Deborah A Thomas; Sherry Pierce; Michael J Keating; Zeev Estrov; Maher Albitar
The prognostic significance of p16(INK4a)/p14(ARF) locus deletion and MDM-2 protein expression in adult acute myelogenous leukemia.
Cancer 2000;89(9):1976-82.
2000: Alvaro Aguayo; Andrew Lamb; Taghi Manshouri; Christy Gidel; Elihu Estey; Deborah Thomas; Charles Koller; Zeev Estrov; Susan O'Brien; Michael Keating; Emil J Freireich; Maher Albitar
Angiogenesis in acute and chronic leukemias and myelodysplastic syndromes.
Blood 2000;96(6):2240-5.
2000: G M Barresi; Maher Albitar; Susan M O'Brien
Acute myeloid leukemia, inversion 16, occurring in a patient with chronic lymphocytic leukemia.
Leukemia & lymphoma 2000;38(5-6):621-5.
2000: Alvaro Aguayo; Susan O'Brien; Michael Keating; Taghi Manshouri; Christy Gidel; Bart Barlogie; Miloslav Beran; Charles Koller; Andrew Lamb; Maher Albitar
Clinical relevance of intracellular vascular endothelial growth factor levels in B-cell chronic lymphocytic leukemia.
Blood 2000;96(2):768-70.
2000: Maher Albitar; Emil J Freireich
Molecular defects in chronic myeloproliferative disorders.
Molecular medicine (Cambridge, Mass.) 2000;6(7):555-67.
2000: Farhad Ravandi-Kashani; Susan O'Brien; Taghi Manshouri; Susan Lerner; S Sim; K Dodd; Andrew Lamb; Emil J Freireich; Michael Keating; Maher Albitar
Variations in the low levels of cyclin D1/BCL1 have prognostic value in chronic lymphocytic leukemia.
Leukemia research 2000;24(6):469-74.
2000: Yang O Huh; Terry L Smith; P Collins; Carlos E Bueso-Ramos; Maher Albitar; Hagop M Kantarjian; Sherry A Pierce; Emil J Freireich
Terminal deoxynucleotidyl transferase expression in acute myelogenous leukemia and myelodysplasia as determined by flow cytometry.
Leukemia & lymphoma 2000;37(3-4):319-31.
2000: C Y Chung; Andrew Lamb; Mohammad A Haidar; P Starostik; Taghi Manshouri; Christy Gidel; Emil J Freireich; Michael Keating; Maher Albitar
Deletions in the 13q14 locus in adult lymphoblastic leukemia: rate of incidence and relevance.
Cancer 2000;88(6):1359-64.
2000: Mohammad A Haidar; Andrew Lamb; Taghi Manshouri; C Y Chang; Susan O'Brien; Emil J Freireich; Michael Keating; Maher Albitar
ATM gene deletion in patients with adult acute lymphoblastic leukemia.
Cancer 2000;88(5):1057-62.
2000: Mohammad A Haidar; Taghi Manshouri; Michael J Keating; Hagop M Kantarjian; Emil J Freireich; Kapil Mehta; Maher Albitar
Downregulation of the p53 tumor suppressor gene and upregulation of the bcl-2 gene in retinoic acid receptor alpha-deficient transgenic mice.
International journal of oncology 2000;16(3):561-5.
2000: K Kaban; Andrew Lamb; Moshe Talpaz; Susan O'Brien; Jorge Cortes; Francis Giles; Sherry Pierce; Maher Albitar
Expression of thrombopoietin and its receptor (c-mpl) in chronic myelogenous leukemia: correlation with disease progression and response to therapy.
Cancer 2000;88(3):570-6.
2000: Stefan Faderl; Hagop M Kantarjian; Deborah A Thomas; Jorge Cortes; Francis Giles; Sherry Pierce; Maher Albitar; Zeev Estrov
Outcome of Philadelphia chromosome-positive adult acute lymphoblastic leukemia.
Leukemia & lymphoma 2000;36(3-4):263-73.
2000: J Faber; Andrew Lamb; M W Roberts; Michael Keating; Emil J Freireich; Maher Albitar
Terminal deoxynucleotidyl transferase-negative acute lymphoblastic leukemia.
Archives of pathology & laboratory medicine 2000;124(1):92-7.
1999: Hagop M Kantarjian; Moshe Talpaz; Susan O'Brien; T Manshouri; Jorge Cortes; Francis Giles; Mary Beth Rios; C M Croce; Maher Albitar
Significance of FHIT expression in chronic myelogenous leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(12):4059-64.
1999: Chung-Wu Lin; Susan O'Brien; J Faber; Taghi Manshouri; Jorge Romaguera; Yang O Huh; Andrew Lamb; Michael Keating; Maher Albitar
De novo CD5+ Burkitt lymphoma/leukemia.
American journal of clinical pathology 1999;112(6):828-35.
1999: Farhad Ravandi; Jorge Cortes; Maher Albitar; Ralph B Arlinghaus; J Qiang Guo; Moshe Talpaz; Hagop M Kantarjian
Chronic myelogenous leukaemia with p185(BCR/ABL) expression: characteristics and clinical significance.
British journal of haematology 1999;107(3):581-6.
1999: Alvaro Aguayo; Elihu Estey; Andrew Lamb; T Mansouri; Christy Gidel; Michael Keating; Francis Giles; Zeev Estrov; Bart Barlogie; Maher Albitar
Cellular vascular endothelial growth factor is a predictor of outcome in patients with acute myeloid leukemia.
Blood 1999;94(11):3717-21.
1999: Issa F Khouri; Ming-Sheng Lee; Jorge Romaguera; N Mirza; Andrew Lamb; Martin Korbling; Maher Albitar; Sergio Giralt; Barry Samuels; Paolo Anderlini; Jose Rodriguez; B von Wolff; James L Gajewski; Fernando Cabanillas; Richard Champlin
Allogeneic hematopoietic transplantation for mantle-cell lymphoma: molecular remissions and evidence of graft-versus-malignancy.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(11):1293-9.
1999: Stefan Faderl; Zeev Estrov; Hagop M Kantarjian; Deborah Thomas; Jorge Cortes; Taghi Manshouri; C C Chan; K J Hays; Sherry Pierce; Maher Albitar
The incidence of chromosome 9p21 abnormalities and deletions of tumor suppressor genes p15(INK4b)/p16(INK4a)/p14(ARF) in patients with acute lymphoblastic leukemia.
Cytokines, cellular & molecular therapy 1999;5(3):159-63.
1999: P Starostik; Susan O'Brien; C Y Chung; Mohammad A Haidar; Taghi Manshouri; Andrew Lamb; Emil J Freireich; Michael Keating; Maher Albitar
The prognostic significance of 13q14 deletions in chronic lymphocytic leukemia.
Leukemia research 1999;23(9):795-801.
1999: Francis Giles; Hagop M Kantarjian; Jorge Cortes; Deborah A Thomas; Moshe Talpaz; Taghi Manshouri; Maher Albitar
Multidrug resistance protein expression in chronic myeloid leukemia: associations and significance.
Cancer 1999;86(5):805-13.
1999: Deborah A Thomas; Jorge Cortes; Susan O'Brien; Sherry Pierce; Stefan Faderl; Maher Albitar; Fredrick B Hagemeister; Fernando Cabanillas; S Murphy; Michael J Keating; Andrew Lamb
Hyper-CVAD program in Burkitt's-type adult acute lymphoblastic leukemia.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1999;17(8):2461-70.
1999: D Seong; Hagop M Kantarjian; Maher Albitar; Ralph B Arlinghaus; Jingping Xu; Moshe Talpaz; Mary Beth Rios; Jie Qiang Guo; Susan O'Brien; Michael J Siciliano
Analysis of Philadelphia chromosome-negative BCR-ABL-positive chronic myelogenous leukemia by hypermetaphase fluorescence in situ hybridization.
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 1999;10(8):955-9.
1999: Stefan Faderl; Hagop M Kantarjian; Taghi Manshouri; C Y Chan; Sherry Pierce; K J Hays; Jorge Cortes; Deborah Thomas; Zeev Estrov; Maher Albitar
The prognostic significance of p16INK4a/p14ARF and p15INK4b deletions in adult acute lymphoblastic leukemia.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(7):1855-61.
1999: DM Beaupre; Moshe Talpaz; Frank C Marini; Richard J Cristiano; Jack A Roth; Zeev Estrov; Maher Albitar; M H Freedman; Razelle Kurzrock
Autocrine interleukin-1beta production in leukemia: evidence for the involvement of mutated RAS.
Cancer research 1999;59(12):2971-80.
1999: R Aboul-Nasr; Elihu H Estey; Hagop M Kantarjian; Emil J Freireich; Michael Andreeff; B J Johnson; Maher Albitar
Comparison of touch imprints with aspirate smears for evaluating bone marrow specimens.
American journal of clinical pathology 1999;111(6):753-8.
1999: R Weinkauff; Elihu H Estey; P Starostik; Kimberly Hayes; Yang O Huh; Cheryl Hirsch-Ginsberg; Michael Andreeff; Michael Keating; Hagop M Kantarjian; Emil J Freireich; Maher Albitar
Use of peripheral blood blasts vs bone marrow blasts for diagnosis of acute leukemia.
American journal of clinical pathology 1999;111(6):733-40.
1999: C M Anderson; Carlos E Bueso-Ramos; S A Wallner; Maher Albitar; T E Rosenzweig; Charles Koller
Primary myeloid leukemia presenting concomitantly with primary multiple myeloma: two cases and an update of the literature.
Leukemia & lymphoma 1999;32(3-4):385-90.
1999: Maher Albitar; Taghi Manshouri; Andrew Lamb; Michael Keating; Zeev Estrov; J Faber; Emil J Freireich; Sherry Pierce; Elihu Estey
Correlation between lower c-mpl protein expression and favorable cytogenetic groups in acute myeloid leukemia.
Leukemia research 1999;23(1):63-9.
1998: P Starostik; Taghi Manshouri; Susan O'Brien; Emil J Freireich; Andrew Lamb; Mohammad A Haidar; Susan Lerner; Michael Keating; Maher Albitar
Deficiency of the ATM protein expression defines an aggressive subgroup of B-cell chronic lymphocytic leukemia.
Cancer research 1998;58(20):4552-7.
1998: M DeLima; Maher Albitar; Susan O'Brien; Sherry Pierce; Andrew Lamb; M Andreeff; Luis Fayad; Michael Keating; Elihu Estey
Comparison of referring and tertiary cancer center physician's diagnoses in patients with leukemia.
The American journal of medicine 1998;104(3):246-51.
1997: A W Bseiso; Hagop M Kantarjian; Jie Qiang Guo; Jorge Cortes; Moshe Talpaz; Charles Koller; Maher Albitar; Michael Keating; Ralph B Arlinghaus
Analysis of the BCR-ABL protein in Philadelphia chromosome-positive adult acute lymphocytic leukemia.
Leukemia 1997;11(9):1583-7.
1997: F A Jung; Antonio C Buzaid; Merrick I Ross; KV Woods; J Jack Lee; Maher Albitar; Elizabeth A Grimm
Evaluation of tyrosinase mRNA as a tumor marker in the blood of melanoma patients.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1997;15(8):2826-31.
1997: Sergio Giralt; Elihu Estey; Maher Albitar; Koen van Besien; Gabriela Rondón; Paolo Anderlini; Susan O'Brien; Issa Khouri; James L Gajewski; RC Mehra; David F Claxton; Borje Andersson; Miloslav Beran; Donna Przepiorka; Charles Koller; Steven M Kornblau; M Kørbling; Michael Keating; Andrew Lamb; Richard Champlin
Engraftment of allogeneic hematopoietic progenitor cells with purine analog-containing chemotherapy: harnessing graft-versus-leukemia without myeloablative therapy.
Blood 1997;89(12):4531-6.
1997: Kapil Mehta; Teresa McQueen; Taghi Manshouri; Michael Andreeff; S Collins; Maher Albitar
Involvement of retinoic acid receptor-alpha-mediated signaling pathway in induction of CD38 cell-surface antigen.
Blood 1997;89(10):3607-14.
1997: Mohammad A Haidar; F Loya; Y Yang; H Lin; Armand B. Glassman; E Goldwasser; Maher Albitar
Electron microscopic localization of lacZ expression in the proximal convoluted tubular cells of the kidney in transgenic mice carrying chimeric erythropoietin/lacZ gene constructs.
Journal of structural biology 1997;118(3):220-5.
1997: Taghi Manshouri; Ying Yang; Hui Lin; Sanford A Stass; Armand B. Glassman; Michael J Keating; Maher Albitar
Downregulation of RAR alpha in mice by antisense transgene leads to a compensatory increase in RAR beta and RAR gamma and development of lymphoma.
Blood 1997;89(7):2507-15.
1997: A R Copeland; Carlos E Bueso-Ramos; FJ Liu; Steven M Kornblau; Yang O Huh; Maher Albitar
Molecular study of hairy cell leukemia variant with biclonal paraproteinemia.
Archives of pathology & laboratory medicine 1997;121(2):150-4.
1996: Mohammad A Haidar; F Loya; Y Yang; H Lin; Armand B. Glassman; Michael J Keating; E Goldwasser; Maher Albitar
Differential expression of lacZ in the liver and kidney of transgenic mice carrying chimeric lacZ-erythropoietin gene constructs with or without its 1.2 kb 3'-flanking sequence.
Nucleic acids research 1996;24(18):3621-8.
1996: Kit-Fai Wong; Kimberly J Hayes; Y O Huh; Maher Albitar; Armand B. Glassman
Translocation (X;10)(p10;p10): A rare but nonrandom chromosomal abnormality in acute leukemia of myeloid differentiation.
Cancer genetics and cytogenetics 1996;86(2):153-5.
1996: S Wright; A Chucrallah; Y Y Chong; H Kantarjian; M Keating; Maher Albitar
Acute lymphoblastic leukemia with myeloperoxidase activity.
American journal of hematology 1996;51(2):147-51.
1996: Carlos E Bueso-Ramos; Taghi Manshouri; Mohammad A Haidar; Y Yang; P McCown; N Ordonez; Armand B. Glassman; Nour Sneige; Maher Albitar
Abnormal expression of MDM-2 in breast carcinomas.
Breast cancer research and treatment 1996;37(2):179-88.
1995: A E Chucrallah; Sanford A Stass; Y O Huh; Maher Albitar; Hagop M Kantarjian
Adult acute lymphoblastic leukemia at relapse. Cytogenetic, immunophenotypic, and molecular changes.
Cancer 1995;76(6):985-91.
1995: Mohammad A Haidar; X B Cao; Taghi Manshouri; L L Chan; Armand B. Glassman; Hagop M Kantarjian; Michael J Keating; Miloslav Beran; Maher Albitar
p16INK4A and p15INK4B gene deletions in primary leukemias.
Blood 1995;86(1):311-5.
1995: Carlos E Bueso-Ramos; Taghi Manshouri; Mohammad A Haidar; Y O Huh; Michael J Keating; Maher Albitar
Multiple patterns of MDM-2 deregulation in human leukemias: implications in leukemogenesis and prognosis.
Leukemia & lymphoma 1995;17(1-2):13-8.
1994: F Loya; Y Yang; H Lin; E Goldwasser; Maher Albitar
Transgenic mice carrying the erythropoietin gene promoter linked to lacZ express the reporter in proximal convoluted tubule cells after hypoxia.
Blood 1994;84(6):1831-6.
1993: Carlos E Bueso-Ramos; Y Yang; E deLeon; P McCown; Sanford A Stass; Maher Albitar
The human MDM-2 oncogene is overexpressed in leukemias.
Blood 1993;82(9):2617-23.